Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
Go back to Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026| AGENUS (NASDAQ: AGEN) | Delayed: 7.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.85 | 52 Week High | $7.49 | |||
| Open | $7.85 | 52 Week Low | $2.61 | |||
| Day High | $7.85 | P/E | N/A | |||
| Day Low | $7.85 | EPS | $-1.10 | |||
| Volume | 124 | |||||
